Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
GeoVax Labs, Inc. (GOVX)
USD1.19
-0.07 (-5.56%)
US NASDAQ Healthcare Biotechnology
Address
1900 Lake Park Drive 30080
Smyrna, GA, US
Smyrna, GA, US
CEO
David Alan Dodd
Website
geovax.com
IPO
2020-09-25
CIK 832489 ISIN US3736787058
Also trades on
NASDAQ Capital Market · GOVX (USD)
NASDAQ Capital Market · GOVXW (USD)
Description
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.19
-0.07 (-5.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5M
Beta
3.63
Float Shares
955.5K
Free Float %
99.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.08% | -29.21% | -5.97% | -25.00% | -88.83% | -70.56% | -94.49% | -99.49% | -99.94% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
1.19
Low
100.00
+8,303.4%
Consensus
100.00
+8,303.4%
Median
100.00
+8,303.4%
High
100.00
+8,303.4%
DCF (Unlevered)
2,339,802.86
+196,621,988.8%
DCF (Levered)
2,339,802.91
+196,621,993.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
100.00
+8,303.4%
|
Quality scores
Altman Z-Score
-96.48
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-37.1% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+81.4% ★ Q1'26: +76.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-917.3%
-
EBIT margin Biotechnology: +0.0%-869.3%
-
ROIC Biotechnology: -16.1%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+361.9% Q1'26: +319.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-38,965.21× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
428.1K
est: 16.20M (-97.4%)
|
828.9K
est: 4.05M (-79.5%)
|
963.0K
est: 900.0K (+7.0%)
|
1.18M
est: 1.20M (-2.0%)
|
1.82M
est: 1.97M (-7.5%)
|
385.5K
est: 220.0K (+75.2%)
|
81.5K
est: 91.0K (-10.4%)
|
—
est: 300.7K (-100.0%)
|
3.95M
est: 5.32M (-25.7%)
|
2.49M
est: 2.50M (-0.4%)
|
2.57M
2.57M – 2.57M
+2.7% YoY
|
519.56M
519.56M – 519.56M
+20,142.5% YoY
|
112.80M
112.80M – 112.80M
-78.3% YoY
|
279.24M
279.24M – 279.24M
+147.6% YoY
|
332.53M
332.53M – 332.53M
+19.1% YoY
|
| EBITDA |
-2.67M
est: -9.72M (+72.6%)
|
-3.24M
est: -2.43M (-33.5%)
|
-2.54M
est: -540.0K (-369.9%)
|
-2.36M
est: -720.0K (-227.5%)
|
-2.79M
est: -1.18M (-136.2%)
|
-18.53M
est: -132.0K (-13,938.3%)
|
-13.97M
est: -54.6K (-25,490.3%)
|
-26.67M
est: -180.4K (-14,682.6%)
|
-24.88M
est: -3.19M (-678.9%)
|
-21.64M
est: -1.50M (-1,342.6%)
|
-1.54M
-1.54M – -1.54M
-2.7% YoY
|
-311.73M
-311.73M – -311.73M
-20,142.5% YoY
|
-67.68M
-67.68M – -67.68M
+78.3% YoY
|
-167.55M
-167.55M – -167.55M
-147.6% YoY
|
-199.52M
-199.52M – -199.52M
-19.1% YoY
|
| EBIT |
-2.69M
est: -9.72M (+72.3%)
|
-3.27M
est: -2.43M (-34.6%)
|
-2.56M
est: -540.0K (-373.6%)
|
-2.37M
est: -720.0K (-228.6%)
|
-2.81M
est: -1.18M (-137.9%)
|
-18.57M
est: -132.0K (-13,967.4%)
|
-14.03M
est: -54.6K (-25,593.3%)
|
-26.74M
est: -180.4K (-14,723.8%)
|
-24.97M
est: -3.19M (-681.9%)
|
-21.64M
est: -1.50M (-1,342.6%)
|
-1.54M
-1.54M – -1.54M
-2.7% YoY
|
-311.73M
-311.73M – -311.73M
-20,142.5% YoY
|
-67.68M
-67.68M – -67.68M
+78.3% YoY
|
-167.55M
-167.55M – -167.55M
-147.6% YoY
|
-199.52M
-199.52M – -199.52M
-19.1% YoY
|
| Net Income |
-2.69M
est: 420.15T (-100.0%)
|
-3.27M
est: -171.17T (+100.0%)
|
-2.56M
est: -31.12T (+100.0%)
|
-2.37M
est: -10.27T (+100.0%)
|
-2.96M
est: -21.01M (+85.9%)
|
-18.57M
est: -91.81M (+79.8%)
|
-14.02M
est: -60.10M (+76.7%)
|
-25.97M
est: -12.26M (-111.9%)
|
-24.99M
est: -115.01M (+78.3%)
|
-21.46M
est: 1.05M (-2,135.9%)
|
-15.61M
-15.61M – -15.61M
-1,580.6% YoY
|
-1.79M
-1.79M – -1.79M
+88.5% YoY
|
5.48M
-451.0K – 11.41M
+406.5% YoY
|
5.93M
5.93M – 5.93M
+8.3% YoY
|
7.08M
7.08M – 7.08M
+19.3% YoY
|
| SGA |
1.43M
est: 239.80M (-99.4%)
|
2.13M
est: 59.95M (-96.4%)
|
1.65M
est: 13.32M (-87.6%)
|
1.64M
est: 17.76M (-90.8%)
|
2.20M
est: 29.19M (-92.5%)
|
3.58M
est: 3.26M (+9.8%)
|
4.99M
est: 1.35M (+270.2%)
|
5.95M
est: 4.52M (+31.5%)
|
5.39M
est: 80.07M (-93.3%)
|
6.01M
est: 37.61M (-84.0%)
|
38.61M
38.61M – 38.61M
+2.7% YoY
|
7.82B
7.82B – 7.82B
+20,142.5% YoY
|
1.70B
1.70B – 1.70B
-78.3% YoY
|
4.20B
4.20B – 4.20B
+147.6% YoY
|
5.00B
5.00B – 5.00B
+19.1% YoY
|
| EPS |
-26.50
est: 81,000,000.00 (-100.0%)
|
-32.25
est: -33,000,000.00 (+100.0%)
|
-25.25
est: -6,000,000.00 (+100.0%)
|
-23.50
est: -1,980,000.00 (+100.0%)
|
-29.00
est: -4.05 (-616.0%)
|
-182.50
est: -17.70 (-931.1%)
|
-138.00
est: -11.59 (-1,090.9%)
|
-255.50
est: -12.79 (-1,898.0%)
|
-120.50
est: -120.00 (-0.4%)
|
-22.40
est: 1.10 (-2,136.4%)
|
-16.29
-16.29 – -16.29
-1,580.6% YoY
|
-1.87
-1.87 – -1.87
+88.5% YoY
|
5.72
-0.47 – 11.90
+406.5% YoY
|
6.19
6.19 – 6.19
+8.3% YoY
|
7.39
7.39 – 7.39
+19.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-16 | D. Boral Capital | Hold | Hold | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-167.59B
OE per share TTM
-61,447.30
Owner's Yield
-6,864,085.30%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9,487,835.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
3
Total invested
6.4K
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Papageorgiou, Stavros | 55.59M | 7.10% | 30.40M | 25.19M | 30.40M | 25.19M | IN | Citizenship or place of organization. | 2009-10-01 | ↗ |
| 2 | Armistice Capital, LLC | 3.11M | 9.99% | — | 3.11M | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 3 | Steven Boyd | 3.11M | 9.99% | — | 3.11M | — | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 4 | Augustine Capital Management, Inc. | 2.40M | 5.70% | — | 2.40M | — | 2.40M | CO | Illinois | 1999-06-07 | ↗ |
| 5 | Augustine Fund, L.P. | 2.40M | 5.70% | — | 2.40M | — | 2.40M | PN | Illinois | 1999-06-07 | ↗ |
| 6 | Brian D. Porter | 2.40M | 5.70% | — | 2.40M | — | 2.40M | IN | Illinois | 1999-06-07 | ↗ |
| 7 | John T. Porter | 2.40M | 5.70% | — | 2.40M | — | 2.40M | IN | Illinois | 1999-06-07 | ↗ |
| 8 | Thomas Duszynski | 2.40M | 5.70% | — | 2.40M | — | 2.40M | IN | Illinois | 1999-06-07 | ↗ |
| 9 | WELCH & FORBES LLC | 1.70M | 5.33% | 1.69M | — | 1.70M | — | IA | Organized under the laws of Delaware | 2015-01-08 | ↗ |
| 10 | Michael Bigger | 251.1K | 4.99% | — | — | — | 251.1K | IN | Delaware | 2021-02-04 | ↗ |
| 11 | Cavalry Fund I Management LLC | 219.3K | 4.99% | 219.3K | — | 219.3K | — | OO | Delaware | 2021-02-10 | ↗ |
| 12 | Thomas Walsh | 219.3K | 4.99% | 219.3K | — | 219.3K | — | IN | United States | 2021-02-10 | ↗ |
| 13 | Bigger Capital Fund GP, LLC | 151.1K | 3.80% | — | — | — | 151.1K | OO | Delaware | 2021-02-04 | ↗ |
| 14 | Bigger Capital Fund, LP | 151.1K | 3.80% | — | — | — | 151.1K | PN | Delaware | 2021-02-04 | ↗ |
| 15 | District 2 Capital Fund LP | 100.0K | 2.60% | — | — | — | 100.0K | PN | Delaware | 2021-02-04 | ↗ |
| 16 | District 2 Capital LP | 100.0K | 2.60% | — | — | — | 100.0K | PN | Delaware | 2021-02-04 | ↗ |
| 17 | District 2 GP LLC | 100.0K | 2.60% | — | — | — | 100.0K | OO | Delaware | 2021-02-04 | ↗ |
| 18 | District 2 Holdings LLC | 100.0K | 2.60% | — | — | — | 100.0K | OO | Delaware | 2021-02-04 | ↗ |
| 19 | L1 Capital Global Opportunities Master Fund Ltd. | — | 0.00% | — | — | — | — | FI | — | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
3
-16 vs prev Q
New positions
1
Closed positions
17
Increased
1
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 615.4K +615.4K (+100.0%) | 105.2K +105.2K (+100.0%) | 3.03% +3.033 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 606.5K +606.5K (+100.0%) | 103.7K +103.7K (+100.0%) | 2.99% +2.990 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 3 | JANE STREET GROUP, LLC | 581.6K +581.6K (+100.0%) | 99.5K +99.5K (+100.0%) | 2.87% +2.867 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 4 | VANGUARD GROUP INC | 244.2K +— (+0.0%) | 41.8K -73.7K (-63.8%) | 1.20% +0.000 pp | 0.00% +0.000 pp | USD25.13 -83.0% | 8 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 207.1K +— (+0.0%) | 35.4K -62.6K (-63.9%) | 1.02% +0.000 pp | 0.00% +0.000 pp | USD33.79 -87.3% | 8 qtrs — |
| 6 | HRT FINANCIAL LP | 185.2K +185.2K (+100.0%) | 31.0K +31.0K (+100.0%) | 0.91% +0.913 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 7 | UBS GROUP AG | 89.5K +31.1K (+53.2%) | 15.3K -12.3K (-44.6%) | 0.44% +0.153 pp | 0.00% +0.000 pp | USD20.31 -78.9% | 6 qtrs — |
| 8 | NORTHERN TRUST CORP | 64.7K +53.0K (+454.3%) | 11.1K +5.5K (+100.4%) | 0.32% +0.261 pp | 0.00% +0.000 pp | USD14.65 -70.8% | 5 qtrs — |
| 9 | XTX TOPCO LTD | 61.0K +61.0K (+100.0%) | 10.4K +10.4K (+100.0%) | 0.30% +0.301 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 10 | FIDUCIARY ALLIANCE LLC | 35.0K +35.0K (+100.0%) | 6.0K +6.0K (+100.0%) | 0.17% +0.173 pp | 0.00% +0.000 pp | USD4.28 +0.0% | 1 qtrs NEW |
| 11 | BLACKROCK, INC. | 27.6K +— (+0.0%) | 4.7K -8.3K (-63.9%) | 0.14% +0.000 pp | 0.00% +0.000 pp | USD60.25 -92.9% | 6 qtrs — |
| 12 | MONETA GROUP INVESTMENT ADVISORS LLC | 800.00 -19.2K (-96.0%) | 3.4K -6.0K (-63.9%) | 0.00% -0.095 pp | 0.00% +0.000 pp | USD16.72 -74.4% | 3 qtrs — |
| 13 | STATE STREET CORP | 16.8K +— (+0.0%) | 2.9K -5.1K (-63.8%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD61.75 -93.1% | 5 qtrs — |
| 14 | ADVISOR GROUP HOLDINGS, INC. | 5.0K -400.0 (-7.4%) | 855.00 -1.8K (-67.9%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD12.92 -66.9% | 5 qtrs — |
| 15 | FARTHER FINANCE ADVISORS, LLC | 494.00 +— (+0.0%) | 84.00 -150.0 (-64.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD21.61 -80.2% | 3 qtrs — |
| 16 | BANK OF AMERICA CORP /DE/ | 264.00 -444.0 (-62.7%) | 45.00 -290.0 (-86.6%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD1.42 +201.4% | 7 qtrs — |
| 17 | WELLS FARGO & COMPANY/MN | 250.00 +— (+0.0%) | 43.00 -75.0 (-63.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD31.60 -86.5% | 8 qtrs — |
| 18 | MORGAN STANLEY | 120.00 -25.0K (-99.5%) | 21.00 -11.9K (-99.8%) | 0.00% -0.123 pp | 0.00% +0.000 pp | USD26.46 -83.8% | 8 qtrs — |
| 19 | QUAKER WEALTH MANAGEMENT, LLC | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs — |
| 20 | ARMISTICE CAPITAL, LLC | — -533.9K (-100.0%) | — -252.6K (-100.0%) | 0.00% -2.632 pp | 0.00% -0.004 pp | USD— | 4 qtrs SOLD |
| 21 | HUDSON BAY CAPITAL MANAGEMENT LP | — -100.0K (-100.0%) | — -47.3K (-100.0%) | 0.00% -0.493 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 22 | SABBY MANAGEMENT, LLC | — -661.4K (-100.0%) | — -312.9K (-100.0%) | 0.00% -3.260 pp | 0.00% -0.362 pp | USD— | 2 qtrs SOLD |
| 23 | SBI SECURITIES CO., LTD. | — -4.1K (-100.0%) | — -1.9K (-100.0%) | 0.00% -0.020 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 24 | SCIENTECH RESEARCH LLC | — -16.1K (-100.0%) | — -7.6K (-100.0%) | 0.00% -0.080 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 25 | CITIGROUP INC | — -9.7K (-100.0%) | — -4.6K (-100.0%) | 0.00% -0.048 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 6.5K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
1.1K
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+1,107
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-07 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 1,107 | 0.67 | 741.69 | 3,494 | D | ↗ |
| 2025-06-05 | Sharkey John W. | Officer | A-Award | A | Stock Option | 70,000 | 2.48 | 173.6K | 70,000 | D | ↗ |
| 2025-06-05 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-06-05 | Reynolds Mark | Officer | A-Award | A | Stock Option | 70,000 | 2.48 | 173.6K | 70,000 | D | ↗ |
| 2025-06-05 | NEWMAN MARK J | Officer | A-Award | A | Stock Option | 70,000 | 2.48 | 173.6K | 70,000 | D | ↗ |
| 2025-06-05 | Morgan Jayne | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-06-05 | McKee Kelly T. Jr. | Officer | A-Award | A | Stock Option | 70,000 | 2.48 | 173.6K | 70,000 | D | ↗ |
| 2025-06-05 | MCNALLY ROBERT T | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-06-05 | Lemerond Nicole | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-06-05 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-06-05 | DODD DAVID A | Director / Officer | A-Award | A | Stock Option | 185,500 | 2.48 | 460.0K | 185,500 | D | ↗ |
| 2025-06-05 | CHASE RANDAL D | Director | A-Award | A | Stock Option | 10,000 | 2.48 | 24.8K | 10,000 | D | ↗ |
| 2025-04-10 | Sharkey John W. | Officer | P-Purchase | A | Common Stock | 6,000 | 0.99 | 5.9K | 6,191 | D | ↗ |
| 2025-04-10 | SPENCER JOHN N JR | Director | P-Purchase | A | Common Stock | 10,000 | 0.98 | 9.8K | 11,402 | D | ↗ |
| 2025-04-01 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 1.08 | 10.8K | 36,661 | D | ↗ |
| 2025-03-31 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 6,800 | 1.08 | 7.3K | 14,013 | D | ↗ |
| 2024-08-12 | Sharkey John W. | Officer | A-Award | A | Stock Option | 15,700 | 2.17 | 34.1K | 15,700 | — | ↗ |
| 2024-08-12 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-12 | Reynolds Mark | Officer | A-Award | A | Stock Option | 15,700 | 2.17 | 34.1K | 15,700 | — | ↗ |
| 2024-08-12 | NEWMAN MARK J | Officer | A-Award | A | Stock Option | 15,700 | 2.17 | 34.1K | 15,700 | — | ↗ |
| 2024-08-12 | Morgan Jayne | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-12 | McKee Kelly T. Jr. | Officer | A-Award | A | Stock Option | 15,700 | 2.17 | 34.1K | 15,700 | — | ↗ |
| 2024-08-12 | MCNALLY ROBERT T | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-12 | Lemerond Nicole | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-12 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-12 | DODD DAVID A | Director / Officer | A-Award | A | Stock Option | 35,000 | 2.17 | 76.0K | 35,000 | — | ↗ |
| 2024-08-12 | CHASE RANDAL D | Director | A-Award | A | Stock Option | 8,050 | 2.17 | 17.5K | 8,050 | — | ↗ |
| 2024-08-09 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 1.95 | 15.6K | 26,661 | — | ↗ |
| 2024-02-22 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 8,209 | 2.27 | 18.7K | 18,661 | — | ↗ |
| 2024-02-21 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 520 | 2.15 | 1.1K | 10,452 | — | ↗ |
| 2024-02-07 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 2,000 | 2.77 | 5.5K | 7,213 | — | ↗ |
| 2023-12-22 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 6,944 | 0.36 | 2.5K | 35,782 | — | ↗ |
| 2023-09-25 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 9,653 | 0.52 | 5.0K | 28,838 | — | ↗ |
| 2023-08-25 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 35,087 | 0.57 | 20.0K | 148,957 | — | ↗ |
| 2023-08-18 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 10,000 | 0.52 | 5.2K | 78,184 | — | ↗ |
| 2023-08-01 | Sharkey John W. | Officer | A-Award | A | Stock Option | 100,000 | 0.76 | 75.5K | 100,000 | — | ↗ |
| 2023-08-01 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-08-01 | Reynolds Mark | Officer | A-Award | A | Stock Option | 100,000 | 0.76 | 75.5K | 100,000 | — | ↗ |
| 2023-08-01 | NEWMAN MARK J | Officer | A-Award | A | Stock Option | 100,000 | 0.76 | 75.5K | 100,000 | — | ↗ |
| 2023-08-01 | Morgan Jayne | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-08-01 | McKee Kelly T. Jr. | Officer | A-Award | A | Stock Option | 15,000 | 0.76 | 11.3K | 15,000 | — | ↗ |
| 2023-08-01 | MCNALLY ROBERT T | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-08-01 | Lemerond Nicole | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-08-01 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-08-01 | DODD DAVID A | Director / Officer | A-Award | A | Stock Option | 250,000 | 0.76 | 188.8K | 250,000 | — | ↗ |
| 2023-08-01 | CHASE RANDAL D | Director | A-Award | A | Stock Option | 50,000 | 0.76 | 37.8K | 50,000 | — | ↗ |
| 2023-04-24 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 32,000 | 0.64 | 20.4K | 113,870 | — | ↗ |
| 2023-04-20 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 8,000 | 0.63 | 5.0K | 68,184 | — | ↗ |
| 2022-12-07 | Morgan Jayne | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-09-21 | CHASE RANDAL D | Director | P-Purchase | A | Common Stock | 10,000 | 1.10 | 11.0K | 36,613 | — | ↗ |
| 2022-08-31 | Lemerond Nicole | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-01 | Sharkey John W. | Officer | P-Purchase | A | Common Stock | 1,000 | 0.82 | 820.00 | 2,860 | — | ↗ |
| 2022-06-27 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 4,464 | 1.12 | 5.0K | 19,185 | — | ↗ |
| 2022-06-21 | CHASE RANDAL D | Director | P-Purchase | A | Common Stock | 10,000 | 1.21 | 12.1K | 26,613 | — | ↗ |
| 2022-06-13 | Sharkey John W. | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,860 | — | ↗ |
| 2022-05-05 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 9,722 | 0.72 | 7.0K | 14,721 | — | ↗ |
| 2022-05-04 | McKee Kelly T. Jr. | Officer | P-Purchase | A | Common Stock | 4,999 | 0.71 | 3.5K | 4,999 | — | ↗ |
| 2022-01-06 | McKee Kelly T. Jr. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-07 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 3.82 | 95.5K | 25,000 | — | ↗ |
| 2021-12-07 | Reynolds Mark | Officer | A-Award | A | Stock Option (right to buy) | 48,200 | 3.82 | 184.1K | 48,200 | — | ↗ |
| 2021-12-07 | NEWMAN MARK J | Officer | A-Award | A | Common Stock (right to buy) | 25,700 | 3.82 | 98.2K | 25,700 | — | ↗ |
| 2021-12-07 | MCNALLY ROBERT T | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 3.82 | 95.5K | 25,000 | — | ↗ |
| 2021-12-07 | Kollintzas Dean G | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 3.82 | 95.5K | 25,000 | — | ↗ |
| 2021-12-07 | DODD DAVID A | Director / Officer | A-Award | A | Stock Option (right to buy) | 103,000 | 3.82 | 393.5K | 103,000 | — | ↗ |
| 2021-12-07 | CHASE RANDAL D | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 3.82 | 95.5K | 25,000 | — | ↗ |
| 2021-08-11 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.79 | 69.8K | 25,000 | — | ↗ |
| 2021-08-11 | Reynolds Mark | Officer | A-Award | A | Stock Option (right to buy) | 128,000 | 2.79 | 357.1K | 128,000 | — | ↗ |
| 2021-08-11 | NEWMAN MARK J | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 2.79 | 97.7K | 35,000 | — | ↗ |
| 2021-08-11 | MCNALLY ROBERT T | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.79 | 69.8K | 25,000 | — | ↗ |
| 2021-08-11 | Kollintzas Dean G | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.79 | 69.8K | 25,000 | — | ↗ |
| 2021-08-11 | DODD DAVID A | Director / Officer | A-Award | A | Stock Option (right to buy) | 273,000 | 2.79 | 761.7K | 273,000 | — | ↗ |
| 2021-08-11 | CHASE RANDAL D | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.79 | 69.8K | 25,000 | — | ↗ |
| 2020-09-29 | SPENCER JOHN N JR | Director | P-Purchase | A | Common Stock Purchase Warrant | 21,024 | 5.00 | 105.1K | 21,024 | — | ↗ |
| 2020-09-29 | Reynolds Mark | Officer | P-Purchase | A | Common Stock Purchase Warrant | 60,184 | 5.00 | 300.9K | 60,184 | — | ↗ |
| 2020-09-29 | MCNALLY ROBERT T | Director | P-Purchase | A | Common Stock | 53,925 | 5.00 | 269.6K | 53,925 | — | ↗ |
| 2020-09-29 | Kollintzas Dean G | Director | P-Purchase | A | Common Stock | 11,987 | 5.00 | 59.9K | 11,987 | — | ↗ |
| 2020-09-29 | DODD DAVID A | Director / Officer | P-Purchase | A | Common Stock | 81,870 | 5.00 | 409.4K | 81,870 | — | ↗ |
| 2020-09-29 | CHASE RANDAL D | Director | P-Purchase | A | Common Stock Purchase Warrant | 16,613 | 5.00 | 83.1K | 16,613 | — | ↗ |
| 2020-08-25 | NEWMAN MARK J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-17 | SPENCER JOHN N JR | Director | A-Award | A | Common Stock Purchase Option | 345,000 | 0.03 | 9.2K | 345,000 | — | ↗ |
| 2018-12-17 | Reynolds Mark | Officer | A-Award | A | Common Stock Purchase Option | 750,000 | 0.03 | 20.0K | 750,000 | — | ↗ |
| 2018-12-17 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Common Stock Purchase Option | 600,000 | 0.03 | 16.0K | 600,000 | — | ↗ |
| 2018-12-17 | MCNALLY ROBERT T | Director | A-Award | A | Common Stock Purchase Option | 650,000 | 0.03 | 17.3K | 650,000 | — | ↗ |
| 2018-12-17 | Kollintzas Dean G | Director | A-Award | A | Common Stock Purchase Option | 300,000 | 0.03 | 8.0K | 300,000 | — | ↗ |
| 2018-12-17 | Guirakhoo Farshad | Officer | A-Award | A | Common Stock Purchase Option | 625,000 | 0.03 | 16.6K | 625,000 | — | ↗ |
| 2018-12-17 | DODD DAVID A | Director / Officer | A-Award | A | Common Stock Purchase Option | 785,000 | 0.03 | 20.9K | 785,000 | — | ↗ |
| 2018-12-17 | CHASE RANDAL D | Director | A-Award | A | Common Stock Purchase Option | 320,000 | 0.03 | 8.5K | 320,000 | — | ↗ |
| 2018-09-01 | DODD DAVID A | Director / Officer | A-Award | A | Stock Purchase Option | 3,000,000 | 0.03 | 90.0K | 3,000,000 | — | ↗ |
| 2017-12-20 | SPENCER JOHN N JR | Director | A-Award | A | Common Stock Purchase Option | 240,000 | 0.05 | 12.0K | 240,000 | — | ↗ |
| 2017-12-20 | Reynolds Mark | Officer | A-Award | A | Common Stock Purchase Option | 750,000 | 0.05 | 37.5K | 750,000 | — | ↗ |
| 2017-12-20 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Common Stock Purchase Option | 450,000 | 0.05 | 22.5K | 450,000 | — | ↗ |
| 2017-12-20 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Common Stock Purchase Option | 750,000 | 0.05 | 37.5K | 750,000 | — | ↗ |
| 2017-12-20 | Kollintzas Dean G | Director | A-Award | A | Common Stock Purchase Option | 170,000 | 0.05 | 8.5K | 170,000 | — | ↗ |
| 2017-12-20 | Guirakhoo Farshad | Officer | A-Award | A | Common Stock Purchase Option | 500,000 | 0.05 | 25.0K | 500,000 | — | ↗ |
| 2017-12-20 | DODD DAVID A | Director | A-Award | A | Common Stock Purchase Option | 270,000 | 0.05 | 13.5K | 270,000 | — | ↗ |
| 2017-12-20 | CHASE RANDAL D | Director | A-Award | A | Common Stock Purchase Option | 200,000 | 0.05 | 10.0K | 200,000 | — | ↗ |
| 2016-12-13 | SPENCER JOHN N JR | Director | A-Award | A | Common Stock Purchase Option | 123,500 | 0.07 | 8.1K | 123,500 | — | ↗ |
| 2016-12-13 | Reynolds Mark | Officer | A-Award | A | Common Stock Purchase Option | 335,000 | 0.07 | 21.8K | 335,000 | — | ↗ |
| 2016-12-13 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Common Stock Purchase Option | 262,200 | 0.07 | 17.1K | 262,200 | — | ↗ |
| 2016-12-13 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Common Stock Purchase Option | 462,500 | 0.07 | 30.2K | 462,500 | — | ↗ |
| 2016-12-13 | Kollintzas Dean G | Director | A-Award | A | Common Stock Purchase Option | 79,275 | 0.07 | 5.2K | 79,275 | — | ↗ |
| 2016-12-13 | Guirakhoo Farshad | Officer | A-Award | A | Common Stock Purchase Option | 85,000 | 0.07 | 5.5K | 85,000 | — | ↗ |
| 2016-12-13 | DODD DAVID A | Director | A-Award | A | Common Stock Purchase Option | 202,800 | 0.07 | 13.2K | 202,800 | — | ↗ |
| 2016-12-13 | CHASE RANDAL D | Director | A-Award | A | Common Stock Purchase Option | 106,700 | 0.07 | 7.0K | 106,700 | — | ↗ |
| 2015-12-11 | SPENCER JOHN N JR | Director | A-Award | A | Stock Purchase Option | 30,000 | 0.11 | 3.3K | 30,000 | — | ↗ |
| 2015-12-11 | Reynolds Mark | Officer | A-Award | A | Stock Purchase Option | 60,000 | 0.11 | 6.6K | 60,000 | — | ↗ |
| 2015-12-11 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Purchase Option | 100,000 | 0.11 | 11.0K | 100,000 | — | ↗ |
| 2015-12-11 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Purchase Option | 75,000 | 0.11 | 8.3K | 75,000 | — | ↗ |
| 2015-12-11 | Kollintzas Dean G | Director | A-Award | A | Stock Purchase Option | 30,000 | 0.11 | 3.3K | 30,000 | — | ↗ |
| 2015-12-11 | Guirakhoo Farshad | Officer | A-Award | A | Stock Purchase Option | 60,000 | 0.11 | 6.6K | 60,000 | — | ↗ |
| 2015-12-11 | DODD DAVID A | Director | A-Award | A | Stock Purchase Option | 30,000 | 0.11 | 3.3K | 30,000 | — | ↗ |
| 2015-12-11 | CHASE RANDAL D | Director | A-Award | A | Stock Purchase Option | 30,000 | 0.11 | 3.3K | 30,000 | — | ↗ |
| 2015-10-19 | Guirakhoo Farshad | Officer | — | D | Stock Option | 40,000 | 0.13 | 5.2K | 0 | — | ↗ |
| 2015-05-05 | CHASE RANDAL D | Director | P-Purchase | A | Common Stock | 9,800 | 0.19 | 1.9K | 39,800 | — | ↗ |
| 2015-04-23 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 10,000 | 0.18 | 1.8K | 66,000 | — | ↗ |
| 2015-04-22 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 10,000 | 0.17 | 1.7K | 56,000 | — | ↗ |
| 2015-04-20 | SPENCER JOHN N JR | Director | P-Purchase | A | Common Stock | 18,000 | 0.17 | 3.0K | 46,625 | — | ↗ |
| 2015-04-20 | CHASE RANDAL D | Director | P-Purchase | A | Common Stock | 30,000 | 0.17 | 5.1K | 30,000 | — | ↗ |
| 2015-03-19 | CHASE RANDAL D | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-12-09 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 25,000 | 0.17 | 4.3K | 25,000 | — | ↗ |
| 2014-12-09 | Reynolds Mark | Officer | A-Award | A | Stock Option | 30,000 | 0.17 | 5.1K | 30,000 | — | ↗ |
| 2014-12-09 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.17 | 5.1K | 30,000 | — | ↗ |
| 2014-12-09 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.17 | 5.1K | 30,000 | — | ↗ |
| 2014-12-09 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 25,000 | 0.17 | 4.3K | 25,000 | — | ↗ |
| 2014-12-09 | DODD DAVID A | Director | A-Award | A | Stock Option | 25,000 | 0.17 | 4.3K | 25,000 | — | ↗ |
| 2013-12-18 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 25,000 | 0.53 | 13.3K | 25,000 | — | ↗ |
| 2013-12-18 | Reynolds Mark | Officer | A-Award | A | Stock Option | 30,000 | 0.53 | 15.9K | 30,000 | — | ↗ |
| 2013-12-18 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.53 | 15.9K | 30,000 | — | ↗ |
| 2013-12-18 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.53 | 15.9K | 30,000 | — | ↗ |
| 2013-12-18 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 25,000 | 0.53 | 13.3K | 25,000 | — | ↗ |
| 2013-12-18 | DODD DAVID A | Director | A-Award | A | Stock Option | 25,000 | 0.53 | 13.3K | 25,000 | — | ↗ |
| 2013-06-05 | ROBINSON HARRIET L | Director / Officer | G-Gift | D | Common Stock | 27,500 | 0.00 | — | 1,173,726 | — | ↗ |
| 2012-12-11 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 25,000 | 0.66 | 16.5K | 25,000 | — | ↗ |
| 2012-12-11 | Reynolds Mark | Officer | A-Award | A | Stock Option | 25,000 | 0.66 | 16.5K | 25,000 | — | ↗ |
| 2012-12-11 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Option | 25,000 | 0.66 | 16.5K | 25,000 | — | ↗ |
| 2012-12-11 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.66 | 19.8K | 30,000 | — | ↗ |
| 2012-12-11 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 25,000 | 0.66 | 16.5K | 25,000 | — | ↗ |
| 2012-12-11 | DODD DAVID A | Director | A-Award | A | Stock Option | 25,000 | 0.66 | 16.5K | 25,000 | — | ↗ |
| 2012-01-31 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 15,000 | 0.67 | 10.1K | 36,000 | — | ↗ |
| 2012-01-16 | Antebi Steven S. | Director | P-Purchase | A | Common Stock | 30,000 | 0.67 | 20.1K | 30,000 | — | ↗ |
| 2011-12-30 | SPENCER JOHN N JR | Director | P-Purchase | A | Common Stock | 14,925 | 0.67 | 10.0K | 28,625 | — | ↗ |
| 2011-12-30 | Reynolds Mark | Officer | A-Award | A | Stock Option | 25,000 | 0.91 | 22.8K | 25,000 | — | ↗ |
| 2011-12-30 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Option | 25,000 | 0.91 | 22.8K | 25,000 | — | ↗ |
| 2011-12-30 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Option | 30,000 | 0.91 | 27.3K | 30,000 | — | ↗ |
| 2011-12-30 | Kollintzas Dean G | Director | P-Purchase | A | Stock Purchase Warrant | 22,388 | 1.00 | 22.4K | 22,388 | — | ↗ |
| 2011-12-30 | DODD DAVID A | Director | A-Award | A | Stock Option | 25,000 | 0.91 | 22.8K | 25,000 | — | ↗ |
| 2011-12-30 | Antebi Steven S. | Director | A-Award | A | Stock Option | 25,000 | 0.91 | 22.8K | 25,000 | — | ↗ |
| 2011-06-22 | ROBINSON HARRIET L | Director / Officer | G-Gift | D | Common Stock | 7,422 | 0.00 | — | 1,051,972 | — | ↗ |
| 2011-01-06 | ROBINSON HARRIET L | Director / Officer | G-Gift | D | Common Stock | 9,714 | 0.00 | — | 1,059,394 | — | ↗ |
| 2010-12-20 | ROBINSON HARRIET L | Director / Officer | G-Gift | D | Common Stock | 33,333 | 0.00 | — | 1,069,108 | — | ↗ |
| 2010-12-10 | SPENCER JOHN N JR | Director | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | Reynolds Mark | Officer | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | ROBINSON HARRIET L | Director / Officer | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | NEWMAN MARK J | Officer | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | MCNALLY ROBERT T | Director / Officer | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | Kollintzas Dean G | Director | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | HILDEBRAND DONALD G | Director | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | DODD DAVID A | Director | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-12-10 | Antebi Steven S. | Director | A-Award | A | Stock Option | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2010-10-15 | MCNALLY ROBERT T | Director / Officer | G-Gift | D | Common Stock | 8,300 | 0.00 | — | 0 | — | ↗ |
| 2010-07-02 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 1,000 | 2.50 | 2.5K | 6,000 | — | ↗ |
| 2010-06-11 | NEWMAN MARK J | Officer | P-Purchase | A | Common Stock | 2,000 | 3.32 | 6.6K | 3,000 | — | ↗ |
| 2010-06-10 | ROBINSON HARRIET L | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 3.30 | 9.9K | 1,100,341 | — | ↗ |
| 2010-06-10 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 300 | 3.30 | 990.00 | 8,300 | — | ↗ |
| 2010-06-09 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 530 | 3.35 | 1.8K | 5,000 | — | ↗ |
| 2010-06-09 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 900 | 3.32 | 3.0K | 8,000 | — | ↗ |
| 2010-06-09 | HILDEBRAND DONALD G | Director | P-Purchase | A | Common Stock | 1,000 | 3.29 | 3.3K | 19,000 | — | ↗ |
| 2010-06-08 | ROBINSON HARRIET L | Director / Officer | P-Purchase | A | Common Stock | 400 | 3.23 | 1.3K | 1,097,341 | — | ↗ |
| 2010-06-08 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 3.25 | 3.3K | 7,000 | — | ↗ |
| 2010-06-08 | DODD DAVID A | Director | P-Purchase | A | Common Stock | 3,702 | 3.25 | 12.0K | 15,725 | — | ↗ |
| 2010-06-04 | ROBINSON HARRIET L | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 3.30 | 9.9K | 1,096,941 | — | ↗ |
| 2010-06-03 | ROBINSON HARRIET L | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.31 | 1.7K | 1,093,941 | — | ↗ |
| 2010-06-01 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 3.49 | 3.5K | 6,000 | — | ↗ |
| 2010-05-21 | Tsolinas Peter M | Director | P-Purchase | A | Common Stock | 2,000 | 4.10 | 8.2K | 431,734 | — | ↗ |
| 2010-05-21 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 3.95 | 4.0K | 4,000 | — | ↗ |
| 2010-05-21 | DODD DAVID A | Director | P-Purchase | A | Common Stock | 88 | 3.70 | 325.60 | 2,746 | — | ↗ |
| 2010-05-20 | SPENCER JOHN N JR | Director | P-Purchase | A | Common Stock | 10,100 | 3.33 | 33.6K | 13,700 | — | ↗ |
| 2010-05-20 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 796 | 3.60 | 2.9K | 2,896 | — | ↗ |
| 2010-05-20 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 3.90 | 3.9K | 3,000 | — | ↗ |
| 2010-05-20 | DODD DAVID A | Director | P-Purchase | A | Common Stock | 699 | 3.35 | 2.3K | 699 | — | ↗ |
| 2010-05-19 | MCNALLY ROBERT T | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 3.40 | 3.4K | 1,000 | — | ↗ |
| 2010-05-18 | Reynolds Mark | Officer | P-Purchase | A | Common Stock | 500 | 3.45 | 1.7K | 2,100 | — | ↗ |
| 2010-03-23 | ROBINSON HARRIET L | Director / Officer | G-Gift | D | Common Stock | 1,111,102 | 0.00 | — | 54,894,889 | — | ↗ |
| 2010-03-23 | HILDEBRAND DONALD G | Director | G-Gift | D | Common Stock | 1,500,000 | 0.00 | — | 52,620,000 | — | ↗ |
| 2010-03-17 | DODD DAVID A | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2010-03-17 | Antebi Steven S. | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2010-01-27 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 50,000 | 0.14 | 7.1K | 231,070,253 | — | ↗ |
| 2010-01-26 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 40,000 | 0.14 | 5.8K | 231,120,253 | — | ↗ |
| 2010-01-25 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 35,000 | 0.14 | 5.1K | 231,160,253 | — | ↗ |
| 2010-01-21 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 25,000 | 0.15 | 3.7K | 231,195,253 | — | ↗ |
| 2010-01-20 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 25,000 | 0.15 | 3.7K | 231,220,253 | — | ↗ |
| 2010-01-19 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 25,000 | 0.15 | 3.6K | 231,245,253 | — | ↗ |
| 2010-01-14 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 52,500 | 0.14 | 7.6K | 231,270,253 | — | ↗ |
| 2010-01-13 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 10,000 | 0.15 | 1.5K | 231,322,753 | — | ↗ |
| 2010-01-12 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 35,000 | 0.15 | 5.3K | 231,332,753 | — | ↗ |
| 2010-01-11 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 50,000 | 0.15 | 7.6K | 231,367,753 | — | ↗ |
| 2010-01-08 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 135,000 | 0.14 | 19.6K | 231,417,753 | — | ↗ |
| 2010-01-07 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 45,000 | 0.15 | 6.8K | 231,552,753 | — | ↗ |
| 2010-01-06 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 65,000 | 0.16 | 10.4K | 231,597,753 | — | ↗ |
| 2010-01-05 | EMORY UNIVERSITY | 10% Owner | S-Sale | D | GeoVax Labs, Inc Common Stock | 32,500 | 0.16 | 5.2K | 231,662,753 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-12.7K
Shares Outstanding
958.5K
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2009 | Robert T. McNally President and Chief Executive Officer | 250.0K | 15.0K | — | — | — | 3.7K | 330.2K | 0.00% | ↗ |
| 2 | 2009 | Harriet L. Robinson Chief Scientific Officer | 250.0K | 10.0K | — | — | — | 3.7K | 325.2K | 0.00% | ↗ |
| 3 | 2009 | Mark W. Reynolds Chief Financial Officer | 150.0K | 10.0K | — | — | — | 94.00 | 221.6K | 0.00% | ↗ |
| 4 | 2009 | Andrew J. Kandalepas Former Senior Vice President (through July 1, 2009) | 119.2K | — | — | — | — | 18.8K | 138.0K | 0.00% | ↗ |
| 5 | 2008 | Robert T. McNally President and Chief Executive Officer | 175.0K | — | — | — | — | 1.3K | 567.4K | 0.00% | ↗ |
| 6 | 2008 | Andrew J. Kandalepas Senior Vice President | 225.0K | — | — | — | — | — | 463.6K | 0.00% | ↗ |
| 7 | 2008 | Harriet L. Robinson Chief Scientific Officer | 234.4K | — | — | — | — | 313.00 | 438.9K | 0.00% | ↗ |
| 8 | 2008 | Harriet L. Robinson Senior Vice-President, Research and Development | 234.4K | — | — | — | — | — | 394.0K | 0.00% | ↗ |
| 9 | 2008 | Robert T. McNally President Chief Executive Officer | 175.0K | — | — | — | — | — | 379.6K | 0.00% | ↗ |
| 10 | 2008 | Donald G. Hildebrand Former President Chief Executive Officer | 90.0K | — | — | — | — | — | 329.0K | 0.00% | ↗ |
| 11 | 2008 | Andrew J. Kandalepas Former Senior Vice President (through July 1, 2009) | 225.0K | — | — | — | — | — | 270.5K | 0.00% | ↗ |
| 12 | 2008 | Mark W. Reynolds Chief Financial Officer | 120.7K | — | — | — | — | — | 166.2K | 0.00% | ↗ |
| 13 | 2007 | Andrew J. Kandalepas Former Senior Vice President (through July 1, 2009) | 205.3K | 10.0K | — | — | — | — | 820.1K | 0.00% | ↗ |
| 14 | 2007 | Mark W. Reynolds Chief Financial Officer | 92.1K | 10.0K | — | — | — | — | 776.9K | 0.00% | ↗ |
| 15 | 2007 | Andrew J. Kandalepas Senior Vice President | 205.3K | 10.0K | — | — | — | — | 403.7K | 0.00% | ↗ |
| 16 | 2007 | Donald G. Hildebrand Former President Chief Executive Officer | 252.6K | — | — | — | — | — | 256.0K | 0.00% | ↗ |
| 17 | 2007 | Harriet L. Robinson Chief Scientific Officer | 14.9K | 10.0K | — | — | — | — | 24.9K | 0.00% | ↗ |
| 18 | 2007 | Harriet L. Robinson Senior Vice-President, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 19 | 2007 | Robert T. McNally President Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 20 | 2007 | Robert T. McNally President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 21 | 2006 | Andrew J. Kandalepas Senior Vice President | 173.5K | — | 2.40M | — | — | — | 2.57M | 93.26% | ↗ |
| 22 | 2006 | Donald G. Hildebrand Former President Chief Executive Officer | 57.5K | 50.0K | — | — | — | — | 108.1K | 0.00% | ↗ |
| 23 | 2006 | Donald G. Hildebrand Former President Chief Executive Officer | 57.5K | 50.0K | — | — | — | 574.00 | 108.1K | 0.00% | ↗ |
| 24 | 2006 | Mark W. Reynolds Chief Financial Officer | 13.2K | 2.0K | — | — | — | — | 15.2K | 0.00% | ↗ |
| 25 | 2006 | Robert T. McNally President Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 26 | 2006 | Harriet L. Robinson Senior Vice-President, Research and Development | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Alan Dodd | Chairman, President & Chief Executive Officer | 387.7K | male |
| Kelly T. McKee Jr. | Chief Medical Officer | 368.6K | — |
| Mark W. Reynolds | Chief Financial Officer & Corporate Secretary | 348.2K | male |
| Mark J. Newman | Chief Scientific Officer | 301.7K | — |
| Jeffrey Welch | Head of Process Development & Manufacturing Operations | — | male |
| John W. Sharkey | Vice President of Business Development | — | — |
| Harriet Latham Robinson | Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board | — | — |
| Thomas O'Brien | Vice President of Quality Systems & Compliance | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GOVX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
